Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry

INTRODUCTION: Similar outcomes have been observed between patients with rheumatoid arthritis (RA) responding to tocilizumab (TCZ) with methotrexate (MTX) who discontinued vs. continued MTX and between patients receiving MTX who added TCZ vs. switched to TCZ monotherapy. This study examined MTX disco...

Descripción completa

Detalles Bibliográficos
Autores principales: Pappas, Dimitrios A., Blachley, Taylor, Zlotnick, Steve, Best, Jennie, Emeanuru, Kelechi, Kremer, Joel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211217/
https://www.ncbi.nlm.nih.gov/pubmed/32232740
http://dx.doi.org/10.1007/s40744-020-00200-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211217/
https://www.ncbi.nlm.nih.gov/pubmed/32232740
http://dx.doi.org/10.1007/s40744-020-00200-z

Ejemplares similares